gyki 52466 has been researched along with Parkinsonian Disorders in 1 studies
GYKI 52466: an AMPA (non-NMDA) receptor antagonist; structure given in first source
Parkinsonian Disorders: A group of disorders which feature impaired motor control characterized by bradykinesia, MUSCLE RIGIDITY; TREMOR; and postural instability. Parkinsonian diseases are generally divided into primary parkinsonism (see PARKINSON DISEASE), secondary parkinsonism (see PARKINSON DISEASE, SECONDARY) and inherited forms. These conditions are associated with dysfunction of dopaminergic or closely related motor integration neuronal pathways in the BASAL GANGLIA.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Megyeri, K | 1 |
| Marko, B | 1 |
| Sziray, N | 1 |
| Gacsalyi, I | 1 |
| Juranyi, Z | 1 |
| Levay, G | 1 |
| Harsing, LG | 1 |
1 other study available for gyki 52466 and Parkinsonian Disorders
| Article | Year |
|---|---|
Effects of 2,3-benzodiazepine AMPA receptor antagonists on dopamine turnover in the striatum of rats with experimental parkinsonism.
Topics: 3,4-Dihydroxyphenylacetic Acid; Analysis of Variance; Animals; Benzodiazepines; Corpus Striatum; Dop | 2007 |